Fast Track To Personalized Therapy

neoGMP® service. Specifically designed to support patient-specific treatments.

The neoGMP® service produces unique plasmid DNA for each patient at a small scale as compared to a single, large-scale lot intended for many patients. The service supports the requirements for rapid manufacturing from a patient-specific sequence while maintaining the high quality you expect from Aldevron.

Features of neoGMP®

  • Rapid turnaround
  • Single-use, product-dedicated materials and equipment
  • Options for parallel processing
  • Quality oversight of key processes and parameters
  • Segregated manufacturing

Download Service Flyer

Aldevron Advantage

  • 22+ year track record in DNA manufacturing
  • Regulatory experience
  • Process optimization expertise
  • Investments in manufacturing process development


Plasmid DNA in Neoantigen Therapy-2

GMP-Source® Gene Synthesis

Designed to meet the needs of rapid clinical gene synthesis for novel cancer treatments based on neoantigens.

Learn More


neoGMP® Resources

Press Release

The rapid production supported by Aldevron's neoGMP® service is paramount to the successful delivery of personalized cancer treatment.
Learn more about our collaboration with Ziopharm Oncology. 

Connect with an Expert

Connect with us to learn more about how our neoGMP® service can be customized to fit your specific neoantigen projects.
Connect with one of our neoGMP® experts to discuss your project.